GLEM LIN MXR 25/5/1000MG TAB

GLEM LIN MXR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 25mg, Linagliptin 5mg, and Metformin 1000mg—three proven antidiabetic agents working synergistically to help regulate blood glucose levels. Empagliflozin works by increasing glucose excretion through urine, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzymes. Metformin improves insulin sensitivity and reduces hepatic glucose production. This triple combination offers effective glycemic control for type 2 diabetes patients. Suitable for adults requiring multi-agent therapy. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight. Consult your doctor before use, especially if you have kidney or liver conditions. Not recommended during pregnancy or breastfeeding without medical supervision.